© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
All News
The Controversy Over Omega-3 Fatty Acids
A failed trial at the American Heart Association leads to pointed fingers at game-changing research on Vascepa, and counter claims of "manufactured controversy."
New Research Details Dietary Dos and Don'ts for Liver Disease
August 03, 2021
Coffee may have some protective properties. Alcohol implicated, again, as a risk factor.
Biotech Company Looking to Detect HCC Early With Liquid Biopsy Based on Microbiome
August 03, 2021
Micronoma, a San Diego company, says its technology picks up signs of very early cancer from disrupted microbiome.
Health Plan Leaders Can Step Up, Lead on PrEP Services
August 02, 2021
Amida Care’s Doug Wirth says they should work with state-level officials to make sure services are covered after Biden administration’s guidance that coverage is mandatory.
Treatment for NSCLC Increasingly and Exquisitely Targeted
August 02, 2021
Newly approved drugs put the brakes on particular “driver mutations,” that when unimpeded, rev up the runaway cell growth and division that characterizes cancer.
Response to Xalkori Linked to MET Gene Amplification in NSCLC
August 02, 2021
Patients with high amplification of the MET gene had a response rate of 38.1%, more than twice the response rate of those with medium amplification.
Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment
August 01, 2021
The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.
Adam Sabloff, VirtualHealth: "If You Don’t Quit, You’ll Win"
July 31, 2021
Adam Sabloff, CEO and founder of VirtualHealth, says his father’s watchwords, “if you don’t quit, you’ll win,” have inspired and motivated him throughout a varied career that has had ups and downs.
FDA Updates: An Interchangeable Biosimilar for Insulin Leads the Week
July 31, 2021
Approval of the first interchangeable biosimilar; new indications for Keytruda, Botox, and Nucala; Shingrix label's expanded to a new patient population; and Ardelyx’s Complete Response Letter round out this week's FDA news.
Common Drugs Associated with Increased Risk for Cardiac Disease, Sudden Death in Elderly Patients
July 30, 2021
Study finds antibiotics, antidepressants, anti-platelets and other drugs contribute to adverse events and mortality.
The Importance of Reinsurance, Per Adam Gottesman of HM Insurance Group
July 30, 2021
In this special episode of Tuning In to the C-Suite podcast, MHE Associate Editor Briana Contreras met with HM Insurance Group Sales Director Adam Gottesman to discuss the ongoing and critical need for reinsurance in healthcare.